• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C末端缺失的p53亚型在神经母细胞瘤中的表达。

Expression of C-terminal deleted p53 isoforms in neuroblastoma.

作者信息

Goldschneider David, Horvilleur Emilie, Plassa Louis-François, Guillaud-Bataille Marine, Million Karine, Wittmer-Dupret Evelyne, Danglot Gisèle, de Thé Hughes, Bénard Jean, May Evelyne, Douc-Rasy Sétha

机构信息

Centre National de Recherche Scientifique, UMR 8126, Institut Gustave Roussy, 94805 Villejuif, France.

出版信息

Nucleic Acids Res. 2006;34(19):5603-12. doi: 10.1093/nar/gkl619. Epub 2006 Oct 5.

DOI:10.1093/nar/gkl619
PMID:17028100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1636465/
Abstract

The tumor suppressor gene, p53, is rarely mutated in neuroblastomas (NB) at the time of diagnosis, but its dysfunction could result from a nonfunctional conformation or cytoplasmic sequestration of the wild-type p53 protein. However, p53 mutation, when it occurs, is found in NB tumors with drug resistance acquired over the course of chemotherapy. As yet, no study has been devoted to the function of the specific p53 mutants identified in NB cells. This study includes characterization and functional analysis of p53 expressed in eight cell lines: three wild-type cell lines and five cell lines harboring mutations. We identified two transcription-inactive p53 variants truncated in the C-terminus, one of which corresponded to the p53beta isoform recently identified in normal tissue by Bourdon et al. [J. C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville and D. P. Lane (2005) Genes Dev., 19, 2122-2137]. Our results show, for the first time, that the p53beta isoform is the only p53 species to be endogenously expressed in the human NB cell line SK-N-AS, suggesting that the C-terminus truncated p53 isoforms may play an important role in NB tumor development.

摘要

肿瘤抑制基因p53在神经母细胞瘤(NB)诊断时很少发生突变,但其功能障碍可能源于野生型p53蛋白的无功能构象或细胞质隔离。然而,p53突变一旦发生,在化疗过程中获得耐药性的NB肿瘤中可以发现。迄今为止,尚未有研究专门针对在NB细胞中鉴定出的特定p53突变体的功能。本研究包括对在八个细胞系中表达的p53进行表征和功能分析:三个野生型细胞系和五个携带突变的细胞系。我们鉴定出两个在C末端截短的转录无活性p53变体,其中一个对应于Bourdon等人最近在正常组织中鉴定出的p53β异构体[J. C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville and D. P. Lane (2005) Genes Dev., 19, 2122-2137]。我们的结果首次表明,p53β异构体是在人NB细胞系SK-N-AS中内源性表达的唯一p53物种,这表明C末端截短的p53异构体可能在NB肿瘤发展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/eadbc972f388/gkl619f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/10f544ed76db/gkl619f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/527d0e603b5d/gkl619f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/f6a21318f3e1/gkl619f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/cb75643868f1/gkl619f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/bfa42924bb68/gkl619f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/4e7e96e0d971/gkl619f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/0f21d65549a1/gkl619f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/a4d1690dbac6/gkl619f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/eadbc972f388/gkl619f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/10f544ed76db/gkl619f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/527d0e603b5d/gkl619f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/f6a21318f3e1/gkl619f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/cb75643868f1/gkl619f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/bfa42924bb68/gkl619f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/4e7e96e0d971/gkl619f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/0f21d65549a1/gkl619f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/a4d1690dbac6/gkl619f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/1636465/eadbc972f388/gkl619f9.jpg

相似文献

1
Expression of C-terminal deleted p53 isoforms in neuroblastoma.C末端缺失的p53亚型在神经母细胞瘤中的表达。
Nucleic Acids Res. 2006;34(19):5603-12. doi: 10.1093/nar/gkl619. Epub 2006 Oct 5.
2
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.神经基因BTG2TIS21/PC3在神经母细胞瘤细胞中通过DeltaNp73alpha经p53特异性反式激活。
J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. doi: 10.1242/jcs.01704. Epub 2005 Mar 1.
3
Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.神经母细胞瘤细胞系中通过纯合缺失产生的一种新的p53突变体的功能特性
Biochem Biophys Res Commun. 2007 Mar 23;354(4):892-8. doi: 10.1016/j.bbrc.2007.01.057. Epub 2007 Jan 22.
4
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.p53的小分子量变体在人黑色素瘤细胞中表达,并由DNA损伤剂顺铂诱导产生。
Clin Cancer Res. 2008 Mar 15;14(6):1659-68. doi: 10.1158/1078-0432.CCR-07-1422. Epub 2008 Feb 29.
5
Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex.有证据表明,神经母细胞瘤细胞中的野生型p53处于一种难以整合到转录复合物中的构象。
Oncogene. 2001 Mar 15;20(11):1307-17. doi: 10.1038/sj.onc.1204251.
6
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.全长p53及其异构体Deltap53在乳腺癌中的表达与突变状态和临床参数的关系。
Mol Cancer. 2006 Oct 20;5:47. doi: 10.1186/1476-4598-5-47.
7
Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines.p53在人神经母细胞瘤和神经上皮瘤衍生细胞系中的表达。
Oncogene. 1992 Jan;7(1):127-33.
8
Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.N型和S型神经母细胞瘤细胞系中p53亚细胞定位及功能的差异
Cell Growth Differ. 1998 Jul;9(7):545-55.
9
Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.卡介苗通过一条即时早期、p53非依赖途径诱导人移行癌细胞系中p21的表达。
Urol Oncol. 2007 May-Jun;25(3):221-7. doi: 10.1016/j.urolonc.2006.07.021.
10
Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells.通过p53途径产生的应激通过线粒体Noxa上调导致阿霉素处理的神经母细胞瘤细胞凋亡。
Oncogene. 2008 Jan 31;27(6):741-54. doi: 10.1038/sj.onc.1210672. Epub 2007 Aug 20.

引用本文的文献

1
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.ATR抑制通过抑制MYCN扩增的神经母细胞瘤中的DNA修复,与靶向MYCN的烷基化PI聚酰胺协同作用。
Cancer Sci. 2025 Jun;116(6):1691-1702. doi: 10.1111/cas.70043. Epub 2025 Mar 7.
2
It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.并非一切都与α有关:在一个回顾性黑色素瘤队列中,p53β变体的高表达与较低的生存概率相关。
Cancer Cell Int. 2023 Oct 4;23(1):228. doi: 10.1186/s12935-023-03083-6.
3
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.

本文引用的文献

1
p53 isoforms can regulate p53 transcriptional activity.p53 异构体可调节 p53 的转录活性。
Genes Dev. 2005 Sep 15;19(18):2122-37. doi: 10.1101/gad.1339905. Epub 2005 Aug 30.
2
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.神经基因BTG2TIS21/PC3在神经母细胞瘤细胞中通过DeltaNp73alpha经p53特异性反式激活。
J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. doi: 10.1242/jcs.01704. Epub 2005 Mar 1.
3
The C terminus of p53 family proteins is a cell fate determinant.p53家族蛋白的C末端是细胞命运的决定因素。
线粒体易位酶 SLC25A5 的抑制和组蛋白去乙酰化是神经母细胞瘤的有效联合治疗方法。
Int J Cancer. 2023 Apr 1;152(7):1399-1413. doi: 10.1002/ijc.34349. Epub 2022 Nov 17.
4
Multiple approaches to repurposing drugs for neuroblastoma.多种方法可将药物重新用于神经母细胞瘤。
Bioorg Med Chem. 2022 Nov 1;73:117043. doi: 10.1016/j.bmc.2022.117043. Epub 2022 Oct 4.
5
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.CDK4 和 MDM2 的扩增:高危神经母细胞瘤亚组的详细研究。
Sci Rep. 2022 Jul 20;12(1):12420. doi: 10.1038/s41598-022-16455-1.
6
The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma Cells.光热疗法的热剂量在人神经母细胞瘤细胞中产生不同的免疫原性。
Cancers (Basel). 2022 Mar 11;14(6):1447. doi: 10.3390/cancers14061447.
7
p53-Mediated Radiosensitization of Lu-DOTATATE in Neuroblastoma Tumor Spheroids.p53 介导的 Lu-DOTATATE 对神经母细胞瘤肿瘤球体的放射增敏作用。
Biomolecules. 2021 Nov 15;11(11):1695. doi: 10.3390/biom11111695.
8
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1.MI-773,一种MDM2/p53轴的破坏剂,通过下调INSM1在神经母细胞瘤中发挥抗癌作用。
Oncol Lett. 2021 Dec;22(6):838. doi: 10.3892/ol.2021.13099. Epub 2021 Oct 18.
9
Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.通过液体活检和计算决策支持实现转移性胰腺神经内分泌癌的个性化一线治疗
Diagnostics (Basel). 2021 Oct 7;11(10):1850. doi: 10.3390/diagnostics11101850.
10
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.针对神经母细胞瘤治疗的 p53-MDM2 通路:希望之光。
Cancer Lett. 2021 Jan 1;496:16-29. doi: 10.1016/j.canlet.2020.09.023. Epub 2020 Sep 29.
Mol Cell Biol. 2005 Mar;25(5):2014-30. doi: 10.1128/MCB.25.5.2014-2030.2005.
4
Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations.通过使用TP53错义突变文库进行数据挖掘对人类疾病中的TP53突变数据库进行重新评估。
Hum Mutat. 2005 Jan;25(1):6-17. doi: 10.1002/humu.20114.
5
Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH.使用一纳克起始DNA和BAC阵列比较基因组杂交技术检测复杂基因组中的单拷贝DNA拷贝数变异。
Nucleic Acids Res. 2004 Jul 29;32(13):e112. doi: 10.1093/nar/gnh108.
6
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.p53靶基因对SH-SY5Y神经母细胞瘤细胞系中p73过表达的差异反应。
J Cell Sci. 2004 Jan 15;117(Pt 2):293-301. doi: 10.1242/jcs.00834.
7
The UMD-p53 database: new mutations and analysis tools.UMD-p53数据库:新突变与分析工具
Hum Mutat. 2003 Mar;21(3):176-81. doi: 10.1002/humu.10187.
8
Parc: a cytoplasmic anchor for p53.Parc:p53的一种细胞质锚定蛋白。
Cell. 2003 Jan 10;112(1):29-40. doi: 10.1016/s0092-8674(02)01255-2.
9
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.突变型TP53对晚期乳腺癌高剂量化疗反应的影响。
Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5.
10
Accumulation of an inactive form of p53 protein in cells treated with TNF alpha.在用肿瘤坏死因子α(TNFα)处理的细胞中,无活性形式的p53蛋白的积累。
Cell Death Differ. 2002 May;9(5):527-37. doi: 10.1038/sj.cdd.4400983.